15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 21.6% per year over the past 5 years.
Net income has grown faster than revenue (27.2% vs 21.6% per year).
Financial health
Total debt ($42.5B) exceeds cash ($7.3B); net debt is $35.2B.
Total debt has grown in line with revenue (20.7% vs 21.6% per year).
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 26.1% of earnings.
The dividend has grown 14.9% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$65.2B
$20.6B
83.0%
0.0%
77.8%
18.4%
—
$42.5B
$7.3B
2024
$45.0B
$10.6B
81.3%
0.0%
74.2%
13.5%
—
$33.6B
$3.3B
2023
$34.1B
$5.2B
79.2%
0.0%
48.6%
8.2%
—
$25.2B
$2.8B
2022
$28.5B
$6.2B
76.8%
0.0%
58.6%
12.6%
—
$16.2B
$2.1B
2021
$28.3B
$5.6B
74.2%
0.0%
62.2%
11.4%
—
$16.9B
$3.8B
2020
$24.5B
$6.2B
77.7%
0.0%
109.8%
13.3%
—
$16.6B
$3.7B
2019
$22.3B
$8.3B
78.8%
0.0%
319.1%
21.2%
—
$15.3B
$2.3B
2018
$21.5B
$3.2B
78.2%
0.0%
32.9%
7.4%
—
$10.3B
$7.3B
2017
$20.0B
-$204M
77.7%
0.0%
-1.8%
-0.5%
—
$13.6B
$6.2B
2016
$18.3B
$2.7B
77.3%
0.0%
19.5%
7.1%
—
$10.3B
$4.6B
2015
$20.0B
$2.4B
0.0%
0.0%
16.5%
6.8%
—
$8.0B
$3.7B
2014
$19.6B
$2.4B
0.0%
0.0%
15.5%
6.6%
—
$8.0B
$3.9B
2013
$23.1B
$4.7B
0.0%
0.0%
26.6%
13.3%
—
$5.2B
$3.8B
2012
$22.6B
$4.1B
0.0%
0.0%
27.7%
11.9%
—
$5.5B
$4.0B
2011
$24.3B
$4.3B
0.0%
0.0%
32.1%
12.9%
—
$7.0B
$5.9B
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$23.0B
$7.1B
85.8%
0.0%
20.9%
5.0%
—
$47.9B
$8.9B
Mar '26
$19.8B
$7.4B
81.9%
0.0%
23.7%
6.3%
—
$39.4B
$5.3B
Dec '25
$19.3B
$6.6B
82.5%
0.0%
25.0%
5.9%
—
$42.5B
$7.3B
Sep '25
$17.6B
$5.6B
82.9%
0.0%
23.5%
4.9%
—
$40.9B
$9.8B
Jun '25
$15.6B
$5.7B
84.3%
0.0%
31.0%
5.6%
—
$34.2B
$3.4B
Mar '25
$12.7B
$2.8B
82.5%
0.0%
17.5%
3.1%
—
$34.5B
$3.1B
Dec '24
$13.5B
$4.4B
82.2%
0.0%
30.9%
5.6%
—
$33.6B
$3.3B
Sep '24
$11.4B
$970M
81.0%
0.0%
6.8%
1.3%
—
$29.0B
$3.4B
Jun '24
$11.3B
$3.0B
80.8%
0.0%
21.9%
4.1%
—
$23.7B
$3.2B
Mar '24
$8.8B
$2.2B
80.9%
0.0%
17.5%
3.5%
—
$24.6B
$2.5B
Dec '23
$9.4B
$2.2B
80.9%
0.0%
20.3%
3.4%
—
$25.2B
$2.8B
Sep '23
$9.5B
-$57M
80.4%
0.0%
-0.5%
-0.1%
—
$17.9B
$2.4B
Jun '23
$8.3B
$1.8B
78.3%
0.0%
15.9%
3.2%
—
$18.2B
$2.7B
Mar '23
$7.0B
$1.3B
76.6%
0.0%
12.0%
2.5%
—
$18.9B
$3.5B
Dec '22
$7.3B
$1.9B
78.8%
0.0%
18.2%
3.9%
—
$16.2B
$2.1B
Sep '22
$6.9B
$1.5B
77.3%
0.0%
14.4%
3.1%
$1.6B
$14.1B
$2.6B
Jun '22
$6.5B
$953M
78.0%
0.0%
11.1%
2.0%
$812M
$14.7B
$2.6B
Mar '22
$7.8B
$1.9B
73.5%
0.0%
20.4%
4.1%
$2.2B
$15.2B
$2.5B
Dec '21
$8.0B
$1.7B
74.4%
0.0%
19.2%
3.5%
—
$16.9B
$3.8B
Sep '21
$6.8B
$1.1B
78.9%
0.0%
14.3%
2.3%
$1.3B
$15.5B
$3.8B
Valuation over time
How the market has priced LLY against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 51.8× (Mar '23) to 52.9× (Sep '26).
The price-to-sales ratio has risen from 11.3× (Mar '23) to 16.7× (Sep '26).
The dividend yield has fallen from 1.1% (Mar '23) to 0.5% (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is LLY growing its revenue and profit?
Over the past 5 years, Lilly (Eli)'s revenue has grown 21.6% per year, and net income grown 27.2% per year. These are computed facts, not advice.
How much debt does LLY have?
As of FY2025, Lilly (Eli) reported $42.5B of total debt against $7.3B of cash.
What is LLY's profit margin?
In FY2025, gross margin was 83.0%, operating margin —, and net margin 31.7%.
What is LLY's P/E ratio?
As of Sep '26, Lilly (Eli) traded at a price-to-earnings ratio of about 52.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.